Tumani, Hayrettin

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

Teunissen, C. E., Petzold, A., Bennett, J. L., Berven, F. S., Brundin, L., Comabella, M., Franciotta, D., Frederiksen, J. L., Fleming, J. O., Furlan, R., et al. (2009) · Neurology

Clinical Laboratory Practices and Quality ControlMultiple Sclerosis Research Studies

Cited by 845

Blood GFAP as an emerging biomarker in brain and spinal cord disorders

Abdelhak, A., Foschi, M., Abu-Rumeileh, S., Yue, J. K., D’Anna, L., Huss, A., Oeckl, P., Ludolph, A. C., Kuhle, J., Petzold, A., et al. (2022) · Nature Reviews Neurology

Traumatic Brain Injury ResearchTraumatic Brain Injury and Neurovascular Disturbances

Cited by 807

Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study

Kuhle, J., Disanto, G., Dobson, R., Adiutori, R., Bianchi, L., Topping, J., Bestwick, J., Meier, U.-C., Marta, M., Costa, G. D., et al. (2015) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 299

Axonal damage markers in cerebrospinal fluid are increased in ALS

Brettschneider, J., Petzold, A., Süßmuth, S. D., Ludolph, A. C., & Tumani, H. (2006) · Neurology

Amyotrophic Lateral Sclerosis ResearchHereditary Neurological Disorders

Cited by 261

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

Stangel, M., Fredrikson, S., Meinl, E., Petzold, A., Stüve, O., & Tumani, H. (2013) · Nature Reviews Neurology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 229

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease

Lill, C. M., Rengmark, A., Pihlstrøm, L., Fogh, I., Shatunov, A., Sleiman, P. M., Wang, L., Liu, T., Lassen, C. F., Meissner, E., et al. (2015) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 205

TDP-43 in Cerebrospinal Fluid of Patients With Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

Steinacker, P., Hendrich, C., Sperfeld, A. D., Jesse, S., von Arnim, C. A. F., Lehnert, S., Pabst, A., Uttner, I., Tumani, H., Lee, V. M.-Y., et al. (2008) · Archives of Neurology

Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Cited by 199

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

Cantó, E., Tintoré, M., Villar, L. M., Costa, C., Nurtdinov, R., Álvarez-Cermeño, J. C., Arrambide, G., Reverter, F., Deisenhammer, F., Hegen, H., et al. (2015) · Brain

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 193

Biobanking of CSF: International standardization to optimize biomarker development

Teunissen, C. E., Tumani, H., Engelborghs, S., & Mollenhauer, B. (2014) · Clinical Biochemistry

Cerebrospinal fluid and hydrocephalusClinical Laboratory Practices and Quality Control

Cited by 137

Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression

Steinacker, P., Verde, F., Fang, L., Feneberg, E., Oeckl, P., Roeber, S., Anderl-Straub, S., Danek, A., Diehl-Schmid, J., Fassbender, K., et al. (2018) · Journal of Neurology, Neurosurgery & Psychiatry

Amyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration Mechanisms

Cited by 129

Neurofilament ELISA validation

Petzold, A., Altintas, A., Andreoni, L., Bartos, A., Berthele, A., Blankenstein, M. A., Buee, L., Castellazzi, M., Cepok, S., Comabella, M., et al. (2010) · Journal of Immunological Methods

Clinical Laboratory Practices and Quality ControlReliability and Agreement in Measurement

Cited by 105

Effect of epileptic seizures on the cerebrospinal fluid–A systematic retrospective analysis.

Tumani, H., Jobs, C., Brettschneider, J., Hoppner, A. C., Kerling, F., & Fauser, S. (2015) · Epilepsy Research

Epilepsy research and treatmentCerebrospinal fluid and hydrocephalus

Cited by 57

Prostaglandin D Synthase (β-trace) in Healthy Human Sleep

Jordan, W., Tumani, H., Cohrs, S., Eggert, S., Rodenbeck, A., Brunner, E., Rüther, E., & Hajak, G. (2004) · Sleep

Circadian rhythm and melatoninSleep and Wakefulness Research

Cited by 56

Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German–Austrian retrospective multicenter study in patients with a clinically-isolated syndrome

Huss, A. M., Halbgebauer, S., Öckl, P., Trebst, C., Spreer, A., Borisow, N., Harrer, A., Brecht, I., Balint, B., Stich, O., et al. (2016) · Journal of Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 54

The increasing role of Kappa free light chains in the diagnosis of multiple sclerosis

Konen, F. F., Schwenkenbecher, P., Jendretzky, K. F., Gingele, S., Sühs, K.-W., Tumani, H., Süße, M., & Skripuletz, T. (2021) · Cells

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 47

Positive cerebrospinal fluid in the 2024 McDonald criteria for multiple sclerosis

Deisenhammer, F., Hegen, H., Arrambide, G., Banwell, B. L., Coetzee, T., Gnanapavan, S., Montalban, X., Tumani, H., Willrich, M. A., & Freedman, M. S. (2025) · eBioMedicine

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 46

Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD

Feneberg, E., Steinacker, P., Volk, A. E., Weishaupt, J. H., Wollmer, M. A., Boxer, A., Tumani, H., Ludolph, A. C., & Otto, M. (2016) · Journal of Neural Transmission

Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

Cited by 36

Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?

Konen, F. F., Wurster, U., Schwenkenbecher, P., Gerritzen, A., Groß, C. C., Eichhorn, P., Harrer, A., Isenmann, S., Lewczuk, P., Lewerenz, J., et al. (2025) · Autoimmunity Reviews

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 31

Prognostic factors for multiple sclerosis symptoms in radiologically isolated syndrome

Fissolo, N., Schaedelin, S., Villar, L. M., Lünemann, J. D., Correale, J., Rejdak, K., Schwab, N., Vilaseca, A., Held, F., García-Merino, A., et al. (2025) · JAMA Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 27

Cystatin C based estimation of chronic kidney disease and amyotrophic lateral sclerosis in the ALS registry Swabia: associated risk and prognostic value

Nagel, G., Kurz, D., Peter, R. S., Rosenbohm, A., Koenig, W., Dupuis, L., Bäzner, H., Börtlein, A., Dempewolf, S., Schabet, M., et al. (2023) · Scientific Reports

Amyotrophic Lateral Sclerosis ResearchChronic Kidney Disease and Diabetes

Cited by 5